SUMMARY A 20 year old woman with pseudohypoparathyroidism, Parkinsonism and no basal ganglia calcifications shown by computed tomography is reported. She has typical features of pseudohypoparathyroidism and biochemical evidence of end-organ resistance to parathyroid hormone. She is mentally retarded and has tremor, rigidity, bradykinesia, and stooped posture. The cause of Parkinsonism in pseudohypoparathyroidism is thought to be basal ganglia calcification. This patient must have another pathophysiology, perhaps directly related to a G protein defect, causing impaired neurotransmission.
Evans, Donley Case history
This 20 year old woman with small stature, obesity, and mental retardation was the product of a normal pregnancy, with vaginal delivery. She weighed 25 kg at birth. She walked at I year, spoke sentences at 2 years, buttoned her clothes at 10 years and rode a bicycle at 11 years. She reads at the first grade level. Menses began at age 12 years. She has seen multiple physicians. One diagnosed "subclinical hypothyroidism" and prescribed thyroid hormone. Another prescribed oral calcium and vitamin D, for unclear reasons. A paediatric neurologist saw her at 12 years old. He found small stature, obesity, dental enamel abnormalities, small fingers and toes, mental retardation, rigidity, and mild tremor. CT of the head was normal. Bone age by radiography was 15 years. On WISC-R testing, VIQ was 47, PIQ 45, and FSIQ 41. Many family members have similar problems (fig 1) . All three sisters are short. Two have dental problems and short fingers and toes. One has "academic problems". Although the father is normal, the mother is short, mildly obese, and has dental abnormalities. Examination of the mother and one sister showed no Parkinsonism. The paternal grandmother has a Parkinsonism syndrome which began at age 55 years. The maternal grandmother is short and mentally retarded; her sister is short, obese, and was institutionalised because of mental retardation. A maternal aunt is short and obese; one of her daughters is mentally retarded, short, and obese.
On examination, she was 145 7cm tall and weighed 78-1 kg. Head circumference was 54 5 cm. She had acne, oily skin, abdominal and breast striae, and excessive hair on the arms, thorax, abdomen, and face. She was Tanner Stage IV in sexual development. Her face was round (fig 2) and the neck short. She had many dental caries and many teeth had "fallen out". Fingers and toes were short with abnormal 4 7 mg/dl (normal 22-42 mg/dl), and parathyroid hormone 69 pg/ml (normal 11-24 pg/ml). T4, T3, and TSH levels were normal. Blood urea nitrogen, serum ceruloplasmin, prolactin, and creatinine were normal, as were all other blood tests. Chromosomes were normal female. Computed tomography showed cerebral atrophy and thickened calvarium, but no basal ganglia calcification. Electroencephalogram showed slowing of background activity and some low voltage beta activity. Repeat WISC-R showed VIQ 63, PIQ 58,
Because she had no complaints related to her Parkinsonism signs, we did not attempt treatment.
Discussion
Pseudohypoparathyroidism is characterised by the body type and by end-organ resistance to parathyroid hormone.3 Serum parathyroid hormone level in this patient was more than four standard deviations above the mean. Endocrinologists felt this confirmed endorgan resistance and the diagnosis of pseudohypoparathyroidism. They felt a parathyroid infusion test was both unnecessary and dangerous.
Fuller Albright first described pseudohypoparathyroidism in 1942,4 emphasising body type, hypocalcaemia, and end-organ resistance to parathyroid hormone. In 1952,5 he described patients with the body type but normal calcium level, calling it "pseudopseudohypoparathyroidism". Since that time, patients with intermittent hypocalcaemia have been described,6 as well as families with pseudohypoparathyroidism where some members had hypocalcaemia and others normal calcium level. 13 Variable expressivity, within families, of some disease manifestations, is seen in pseudohypoparathyroidism. This variability often involves the serum calcium level and the other endocrine manifestations. It may also include Parkinsonism, with some family members affected and others not. This is seen in this proband's family, probably in Spillane and Spillane's brothers,32 and perhaps in Hermans et al's family. 33 The explanation for variable expressivity in pseudohypoparathyroidism is obscure.
The inheritance of pseudohypoparathyroidism is also obscure.3 Most families follow either x-linked dominant or autosomal dominant inheritance, with females preferentially affected. This patient's family is consistent with either type of inheritance.
In addition to parathyroid hormone resistance, pseudohypoparathyroid patients often have evidence of end-organ resistance to other hormones, especially TSH, gonadotropins, and glucagon.'4 Hormone resistance is probably due to a deficiency in G protein activity,3 although this is not proven.15 G proteins, or guanine nucleotide-binding proteins, are a family of polyproteins that functions in transducing and amplifying a signal from a cell surface receptor (such as the parathyroid hormone receptor) to an effector molecule (adenylate cyclase in the case of parathyroid hormone).
G proteins may also function as intermediaries in the signal transmission of neurotransmitters as well as hormones.' 167 In these cases, a G protein would receive a signal from a cell surface receptor (a2-and IJ-adrenergic, muscarinic, somatostatin, or GABA)17 and then excite or inhibit an effector molecule (adenylate cyclase, calcium channels, potassium channels, or phospholipase C). '7 18 If the G protein excites adenylate cyclase, it is called G.; if it inhibits, Gi, and if no effect, Go. These three types share protein subunits.
Proteins and mRNAs for all three types of G are present in brain. 19 20 Pseudohypoparathyroid 
